Advanced De novo Hepatocellular Carcinoma (HCC) in a Non-Cirrhotic Hepatitis C Patient 15 Years After Sustained Virologic Response (SVR)

Antony Andrew; Lee Tai-Ping

首页> 外文期刊>The American Journal of Gastroenterology >Advanced De novo Hepatocellular Carcinoma (HCC) in a Non-Cirrhotic Hepatitis C Patient 15 Years After Sustained Virologic Response (SVR)

【24h】

Advanced De novo Hepatocellular Carcinoma (HCC) in a Non-Cirrhotic Hepatitis C Patient 15 Years After Sustained Virologic Response (SVR)

机译：在持续的病毒学反应（SVR）后15年内的非肝硬化丙型肝炎患者中的先进的DE Novo肝细胞癌（HCC）

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《The American Journal of Gastroenterology》 |2018年第2期|共2页
作者
Antony Andrew; Lee Tai-Ping;
展开▼
作者单位

Northwell Hlth Manhasset NY USA;

Zucker Sch Med Hofstra Northwell Manhasset NY USA;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类消化系及腹部疾病;
关键词

相似文献

外文文献
中文文献
专利

1. Advanced De novo Hepatocellular Carcinoma (HCC) in a Non-Cirrhotic Hepatitis C Patient 15 Years After Sustained Virologic Response (SVR) [J] . Antony Andrew, Lee Tai-Ping The American Journal of Gastroenterology . 2018,第Suppla2期

机译：在持续的病毒学反应（SVR）后15年内的非肝硬化丙型肝炎患者中的先进的DE Novo肝细胞癌（HCC）
2. De novo hepatocellular carcinoma in a patient with chronic hepatitis C 5 years after sustained virologic response to interferon/ribavirin therapy. [J] . Sieja KS, Everson GT Digestive Diseases and Sciences . 2006,第3期

机译：在对干扰素/利巴韦林治疗产生持续病毒学应答后的5年内，在患有慢性丙型肝炎的患者中从头发生了肝细胞癌。
3. De novo hepatocellular carcinoma in a patient with chronic hepatitis C 5 years after sustained virologic response to interferon/ribavirin therapy. [J] . Sieja KS, Everson GT Digestive Diseases and Sciences . 2006,第3期

机译：在对干扰素/利巴韦林治疗产生持续病毒学应答后的5年内，在患有慢性丙型肝炎的患者中从头发生了肝细胞癌。
4. Predictability of Sustained Virological Response (SVR) in Patients with HCV/HIV Co-infection During Combination Therapy With Peginterferon Alfa-2A (40KD) (PEGASYS~R) Plus Ribavirin (COPEGUS~R) in the APRICOT Trial [C] . M. Rodriguez Torres, F.J. Torriani, E. Lissen International AIDS Conference . 2004

机译：HCV / HIV与Peginterferon Alfa-2a（40KD）（Pegasys〜R）加上利韦韦林（Copegus〜R）在杏试验期间HCV / HIV CONOMENT患者持续病毒学反应（SVR）的可预测性
5. Baseline Toronto HCC Risk Index (THRI) and Albumin Predict Low Risk of Hepatocellular Carcinoma (HCC) after Sustained Virological Response (SVR) in HCV Infection [D] . Lau, Jason. 2019

机译：基线多伦多HCC风险指数（THRI）和白蛋白预测HCV感染持续病毒响应（SVR）后肝细胞癌（HCC）的低风险
6. Risk of Hepatocellular Carcinoma after Sustained Virologic Response in Veterans with HCV-infection Running Head: HCC after SVR [O] . Hashem B. El-Serag, Fasiha Kanwal, Peter Richardson, -1

机译：HCV感染退伍军人持续进行病毒学应答后发生肝细胞癌的危险运行负责人：SVR后发生HCC
7. HEPATOCELLULAR CARCINOMA IN A NON-CIRRHOTIC PATIENT WITH SUSTAINED VIROLOGICAL RESPONSE AFTER HEPATITIS C TREATMENT [O] . Angelo Alves de MATTOS, Patrícia dos Santos MARCON, Fernanda Schild Branco de ARAÚJO, 2015

机译：肝硬化患者肝细胞癌在肝硬化患者治疗后持续的病理反应中的肝细胞癌

Advanced De novo Hepatocellular Carcinoma (HCC) in a Non-Cirrhotic Hepatitis C Patient 15 Years After Sustained Virologic Response (SVR)

著录项

相似文献

相关主题

期刊订阅